1. Breast cancer: JAK/STAT signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 2. Colorectal cancer: Notch signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 3. Lung cancer: Akt/PKB signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 4. Leukemia: Hedgehog signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 5. Gastric cancer: AMPK signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 6. Pancreatic cancer: Wnt signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 7. Cervical cancer: TGFβ signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 8.
Ovarian cancer: VEGF signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 9. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 10. Endometrial cancer: cAMP-dependent signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 11. Lymphoma: TLR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 12. Thyroid cancer: MAPK/Erk signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 13. Kidney cancer: mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 14. Liver cancer: Insulin signal transduction pathway dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 15. Bladder cancer: PI3K/Akt/mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 16.
Skin cancer: Eph/ephrin signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives 17. Esophageal Cancer: Nodal signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives.